课题基金 / 基金详情

Specialized pro-resolving mediators: A novel therapeutic approach for the treatment of Duchenne muscular dystrophy.

Specialized pro-resolving mediators: A novel therapeutic approach for the treatment of Duchenne muscular dystrophy.
专门的促解决介质：一种治疗杜氏肌营养不良症的新型治疗方法。
批准号：
367724
负责人：
Dumont Nicolas
金额：
$5.46万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-05-01 至 2020-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=367724&lang=en
关键词：
Bioactive Lipids Duchenne Muscular Dystrophy Inflammation Ipsc Myoblasts Myogenesis Regenerative Medicine Satellite Cell Skeletal Muscle Regeneration Specialized Lipid Pro-Resolving Mediators

项目摘要

项目成果

Dumont Nicolas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Duchenne muscular dystrophy is a severe disease characterized by progressive and irreversible muscle wasting. Dystrophic patients display ambulatory dysfunctions in early childhood that quickly degenerates into respiratory dysfunctions and premature death
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting defective cells to restore myogenesis and muscle function in myotonic dystrophy type 1
Therapeutic potential of bioactive lipids as anti-fibrotic therapy for muscle regeneration and dystrophies.
Impact of transient neonatal hyperoxia on skeletal muscle development: Relevance for impaired exercise capacity after preterm birth.
Therapeutic potential of resolvins for the treatment of Duchenne muscular dystrophy
海外基金